Abstract:
Antithyroid drugs adverse effects are varied and rare. Autoimmune disorders (vasculitis, lupus erythematosus, polyarthritis . . .) are unusual and serious complications of antithyroid drugs. Since 1945, fewer than 100 cases of systemic manifestations related to antithyroid drugs have been reported in the literature, most frequently with propylthiouracil. The outcome is usually good after drug discontinuation, but some fatal cases have been reported. Because possible cross-sensitivity with other antithyroid drugs, the appropriate treatment for hyperthyroidism relapse if a patient has had an antithyroid drug adverse reaction, should be 131I-Iodine or surgery. We report four new cases of systemic manifestations during propylthiouracil therapy.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 27 August 1996 / Accepted: 23 July 1998
Rights and permissions
About this article
Cite this article
Mathieu, E., Fain, O., Sitbon, M. et al. Systemic Adverse Effect of Antithyroid Drugs. Clin Rheumatol 18, 66–68 (1999). https://doi.org/10.1007/s100670050057
Issue Date:
DOI: https://doi.org/10.1007/s100670050057